Effect of urinary trypsin inhibitor MR-20 in shock.
D000818:Animals; D003402:Creatine Kinase / Q000097:blood; D004285:Dogs; D005966:Glucuronidase / Q000097:blood; D006023:Glycoproteins / Q000494:pharmacology / Q000627:therapeutic use*; D006439:Hemodynamics / Q000187:drug effects; D007668:Kidney / Q000187:drug effects / Q000503:physiopathology; D012079:Renal Circulation; D012769:Shock / Q000097:blood / Q000503:physiopathology; D012771:Shock, Hemorrhagic / Q000188:drug therapy*; D012772:Shock, Septic / Q000188:drug therapy*; D014357:Trypsin / Q000097:blood; D014361:Trypsin Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*
D006023:Glycoproteins; D014361:Trypsin Inhibitors; D003402:Creatine Kinase; D005966:Glucuronidase; D014357:Trypsin; C028665:urinastatin